Cargando…
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451738/ https://www.ncbi.nlm.nih.gov/pubmed/34545184 http://dx.doi.org/10.1038/s41375-021-01418-8 |
| _version_ | 1784569909366226944 |
|---|---|
| author | Marchesi, Francesco Pimpinelli, Fulvia Giannarelli, Diana Ronchetti, Livia Papa, Elena Falcucci, Paolo Pontone, Martina Di Domenico, Enea Gino di Martino, Simona Laquintana, Valentina Mandoj, Chiara Conti, Laura Cordone, Iole La Malfa, Antonia Viggiani, Caterina Renzi, Daniela Palombi, Francesca Romano, Atelda Pisani, Francesco Gumenyuk, Svitlana Di Bella, Ornella Vujovic, Branka Morrone, Aldo Ciliberto, Gennaro Ensoli, Fabrizio Mengarelli, Andrea |
| author_facet | Marchesi, Francesco Pimpinelli, Fulvia Giannarelli, Diana Ronchetti, Livia Papa, Elena Falcucci, Paolo Pontone, Martina Di Domenico, Enea Gino di Martino, Simona Laquintana, Valentina Mandoj, Chiara Conti, Laura Cordone, Iole La Malfa, Antonia Viggiani, Caterina Renzi, Daniela Palombi, Francesca Romano, Atelda Pisani, Francesco Gumenyuk, Svitlana Di Bella, Ornella Vujovic, Branka Morrone, Aldo Ciliberto, Gennaro Ensoli, Fabrizio Mengarelli, Andrea |
| author_sort | Marchesi, Francesco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8451738 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84517382021-09-21 Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas Marchesi, Francesco Pimpinelli, Fulvia Giannarelli, Diana Ronchetti, Livia Papa, Elena Falcucci, Paolo Pontone, Martina Di Domenico, Enea Gino di Martino, Simona Laquintana, Valentina Mandoj, Chiara Conti, Laura Cordone, Iole La Malfa, Antonia Viggiani, Caterina Renzi, Daniela Palombi, Francesca Romano, Atelda Pisani, Francesco Gumenyuk, Svitlana Di Bella, Ornella Vujovic, Branka Morrone, Aldo Ciliberto, Gennaro Ensoli, Fabrizio Mengarelli, Andrea Leukemia Letter Nature Publishing Group UK 2021-09-20 2022 /pmc/articles/PMC8451738/ /pubmed/34545184 http://dx.doi.org/10.1038/s41375-021-01418-8 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter Marchesi, Francesco Pimpinelli, Fulvia Giannarelli, Diana Ronchetti, Livia Papa, Elena Falcucci, Paolo Pontone, Martina Di Domenico, Enea Gino di Martino, Simona Laquintana, Valentina Mandoj, Chiara Conti, Laura Cordone, Iole La Malfa, Antonia Viggiani, Caterina Renzi, Daniela Palombi, Francesca Romano, Atelda Pisani, Francesco Gumenyuk, Svitlana Di Bella, Ornella Vujovic, Branka Morrone, Aldo Ciliberto, Gennaro Ensoli, Fabrizio Mengarelli, Andrea Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas |
| title | Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas |
| title_full | Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas |
| title_fullStr | Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas |
| title_full_unstemmed | Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas |
| title_short | Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas |
| title_sort | impact of anti-cd20 monoclonal antibodies on serologic response to bnt162b2 vaccine in b-cell non-hodgkin’s lymphomas |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451738/ https://www.ncbi.nlm.nih.gov/pubmed/34545184 http://dx.doi.org/10.1038/s41375-021-01418-8 |
| work_keys_str_mv | AT marchesifrancesco impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT pimpinellifulvia impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT giannarellidiana impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT ronchettilivia impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT papaelena impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT falcuccipaolo impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT pontonemartina impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT didomenicoeneagino impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT dimartinosimona impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT laquintanavalentina impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT mandojchiara impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT contilaura impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT cordoneiole impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT lamalfaantonia impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT viggianicaterina impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT renzidaniela impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT palombifrancesca impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT romanoatelda impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT pisanifrancesco impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT gumenyuksvitlana impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT dibellaornella impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT vujovicbranka impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT morronealdo impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT cilibertogennaro impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT ensolifabrizio impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas AT mengarelliandrea impactofanticd20monoclonalantibodiesonserologicresponsetobnt162b2vaccineinbcellnonhodgkinslymphomas |